Treatment Options

Ipi (Yervoy) Nivo (Opdivo) Combination Therapy

Your questions answered about the Ipi (Yervoy) Nivo (Opdivo) Combination Therapy with Dr. Richard Joseph, MD. My doctor is recommending the IPI/Nivo combination as my best shot at beating my […]

Newly Approved Therapies for Stage III Melanoma Patients

We are in a fortunate time for melanoma patients.  Never have we had effective adjuvant therapy with tolerable toxicity, and perhaps we can reach the milestone of a sharp reduction […]

Are Melanoma Clinical Trials for You?

Melanoma Clinical Trials Although we now have some newly discovered therapies for melanoma treatment, the promise for treating melanoma lies in clinical trials; where new agents are tried out in […]

Melanoma: Current Concerns in Treatment & Research

The Doctor Is In: Dr. Richard Joseph, MD Dr. Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer […]

Stage III Adjuvant Therapy: Difficult Decision Making

Guest Blogger: Jason Luke, MD, FACP (Assistant Professor of Medicine, The University of Chicago Medicine) The number of available therapies for the treatment of unresectable or metastatic melanoma has dramatically […]

From Outside the Halls of ASCO

Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer Center. He is a voting member of the NCCN […]

TIL Therapy for Melanoma: Magic Bullet? Or?

TIL Therapy also known as the ACT or adoptive cell transfer, is a therapy of great interest to many patients. There are some small trials currently ongoing at the National […]

Discerning Hype from Hope

The media often has an exciting story headline that there is a new “cure” for melanoma. But before you get your hopes up, read further into these articles. Often it […]

Compassionate Use Isn’t Compassionate to All

The much reported story of Josh, a 7 year old child who needed an antibiotic drug not yet FDA approved to save his life, had a happy ending where his […]

Expanded Access Program (EAP): Patients Are a Virtue!

A happy day arrived last week for melanoma patients! Merck announced the promising melanoma therapy, PD1, is going to be made available to those who have failed prior therapies. This […]

  • Page 1 of 2
  • 1
  • 2